Share the Video:

Improving study design in trials using psychedelic-assisted therapies

Ingmar Gorman, Erika Dyck, Tehseen Noorani

Psychedelic research has gained the attention of the scientific community, popular media, and the public at large. With the expansion of the field, people seeking to participate in such studies may bring a set of expectations that can undermine the validity of trial outcomes. Increased methodological rigor is needed to address this, as well as some of the inherent challenges to psychedelic research, such as difficulty with blinding. In the effort to control bias, there is the risk of losing the impact of subjectivity in psychedelic clinical trials. Some studies seek to isolate the “drug effect” from the phenomenological experience of participants. How do we navigate this tension?

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Building the next generation of psychedelic retreat centers

Psychedelic retreat centers are operating worldwide, with Oregon and Colorado preparing to regulate similar centers. These venues offer access to psychedelic experiences outside clinical settings, raising questions about their differences

Alexandra Pallas, Melissa Stangl, Ann “Annie Oak” Harrison

PS2023 Harm Reduction Integration Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research

Responding to Crises and Calls with Psychedelic Harm Reduction

Panelists from Zendo Project, Fireside Project, Kosmicare, and Anashim Tovim discuss harm reduction strategies in the psychedelic ecosystem, emphasizing innovation, compassion, and scientific expertise in diverse settings. They provide case

Joshua White, Daniel E Martin, Pinni Baumol, Shirelle Noble, Ben Halper

PS2023 Integration Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research Social and Cultural

Psychedelic Outcomes: Intersection of Environment, Self-Identity, and Success ( The POIESIS Study)

The POIESIS study explores how self-identity dimensions influence preferences in a psychedelic dosing environment. Initial findings show stronger connections to spiritual/religious identity compared to racial/ethnic identity. Ongoing efforts aim to

Cody J Wenthur

PS2023 Integration Psychedelic Assisted Therapy Psychedelic Science Research Resources for Therapists

The Legacy of Stanislav Grof

Stanislav Grof, a pioneer in psychedelic research, presents the Grof® Legacy Training on 'holotropic' states of consciousness, with colleagues from international psychedelic training programs.

Brigitte Grof, Stanislav Grof, Diane Haug, Javier Charme, Neil Hannon, Jay Dufrechou

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research Research and Science Resources for Therapists

The State of Psychedelic Research Since 2017

Drs. Summergrad and Insel reflect on the progress and remaining questions in psychedelic science since 2017. They delve into topics like efficacy, regulation, therapy, and provider experience.

Paul Summergrad, Tom Insel, Rachel Nuwer

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research Social and Cultural Spirituality

Tempering Psychedelics: A Conversation with Michael Pollan and Bob Jesse

Michael Pollan, an influential author, sparked interest in psychedelic research with his book "How to Change Your Mind." Bob Jesse, a key figure in the resurgence of psychedelics, has made

Robert Jesse, Michael Pollan

PS2023 MDMA Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research Research and Science

Priorities for the next generation of psychedelic science

NIMH Director Joshua A. Gordon and trauma researcher Barbara O. Rothbaum discuss the current state and future directions of psychedelic research, emphasizing the need for deeper understanding and robust study

Joshua A Gordon

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research Social Justice

TREAT CALIFORNIA-Providing $5 Billion to Fund Psychedelic Research and Therapies

TREAT California initiative aims to transform mental healthcare in California with $5 Billion funding for psychedelic medicine research and access, inspired by successful stem cell agency model.

Jeannie Moller Fontana

PS2023 Healing for All Integration Psychedelic Assisted Therapy Psychedelic Science Psychotherapy Research

The Love Project: Preliminary outcomes of a survey study among psychedelic users

Psychedelic-assisted therapy commonly involves experiences of self-love, love towards others, love received, and being in love. Research explores these experiences' healing potential and integration in therapy.

Improving study design in trials using psychedelic-assisted therapies

Become a MAPS Member with a monthly donation

Related Videos